Geniposide
CAS No. 24512-63-8
Geniposide ( Geniposide )
Catalog No. M13712 CAS No. 24512-63-8
Geniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 54 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGeniposide
-
NoteResearch use only, not for human use.
-
Brief DescriptionGeniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity.
-
DescriptionGeniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity. Geniposide has been shown to regulate Nrf2 translocation.
-
SynonymsGeniposide
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number24512-63-8
-
Formula Weight388.37
-
Molecular FormulaC17H24O10
-
Purity>98%(HPLC)
-
SolubilityWater: 78 mg/mL (200.83 mM); DMSO: 78 mg/mL (200.83 mM)
-
SMILESO=C(C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@]3([H])C(CO)=CC[C@]13[H])OC
-
Chemical NameMethyl (1R,2S,6S)-9-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-oxabicyclo[4.3.0]nona-4,8-diene-5-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang Y, et al. Neurochem Int. 2015 Apr 13. pii: S0197-0186(15)00063-7.
molnova catalog
related products
-
Isoviolanthin
Isoviolanthin reduces the migratory and invasive capacities of TGF-β1-treated HCC cells but exhibits no cytotoxic effects on normal live cells, and has potential as a therapeutic agent for the treatment of advanced-stage metastatic HCC.
-
Brr2 Inhibitor C9
Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
-
SGN-2FF
SGN-2FF is an oral fucosyltransferase inhibitor with antitumor activity.